Article Details
Retrieved on: 2018-04-16 18:15:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Sanofi has been reshaping its business in recent months, spending more than $16 billion to buy biotech company Ablynx and U.S. haemophilia specialist Bioverativ, but also selling off some assets. This week, it sold some brands to <b>Charterhouse Capital Partners</b>' Cooper-Vemedia drugs manufacturing ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here